FDA Aprroves HIV Drug Isentress for Pediatric Use

by Dr. Trupti Shirole on  December 22, 2011 at 11:22 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

The Food and Drug Administration (FDA) approved HIV drug Isentress (raltegravir) for use among children and adolescents aged 2-18 years. This Merck & Co. drug is part of a group of antiviral drugs called integrase inhibitors that block the virus from infecting cells and reproducing.
 FDA Aprroves HIV Drug Isentress for Pediatric Use
FDA Aprroves HIV Drug Isentress for Pediatric Use

Isentress which was approved in 2007 for adults is a twice-a-day pill and is also available as a chewable tablet. However, only the tablet form has been approved for children aged 2-11. The most common side effects among patients include insomnia and headaches.

Edward Cox of the FDA's center for drug evaluation and research said, "Many young children and adolescents are living with HIV and this approval provides an important additional option for their treatment."

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Oral Health And AIDS Drug Toxicity AIDS/HIV AIDS/HIV - Epidemiology AIDS/HIV - Clinical Features AIDS/HIV - Health Education AIDS/HIV - Prevention And Transmission AIDS / HIV - Treatment AIDS/HIV- Lab Tests and Faqs Signature Drug Toxicity 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive